WBA250110C13000
- 0.01
- -0.01-50.00%
Walgreens Boots Alliance Newsroom
Morgan Stanley Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Challenges and Uncertainties Lead to Sell Rating for Walgreens Boots Alliance
Walgreens Boots Alliance Options Spot-On: On January 8th, 146.61K Contracts Were Traded, With 1.01 Million Open Interest
On January 8th ET, $Walgreens Boots Alliance(WBA.US)$ had active options trading, with a total trading volume of 146.61K options for the day, of which put options accounted for 38.62% of the total
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Maintains Target Price $14
Walgreens Boots Alliance (WBA) Q1 Earnings Preview: Here's What to Expect
Should Walgreens Stock Be in Your Portfolio Before Q1 Earnings?
Earnings Preview: WBA to Report Financial Results Pre-market on January 10
$Walgreens Boots Alliance(WBA.US)$ is scheduled to release its financial results pre-market on January 10 ET. Earnings PreviewAnalysts estimate $Walgreens Boots Alliance(WBA.US)$ to post revenue of
Concerns Over Walgreens Potential Acquisition by Sycamore Overshadows Fundamentals, UBS Says
Walgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?
J.P. Morgan Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Announces Target Price $15
Strategic Positioning of Walgreens Boots Alliance: Enhancing Performance Amidst Transformation Initiatives
Super Micro, Microsoft, Nvidia, MicroStrategy, Plug Power, VeriSign, and More Stock Market Movers
Reflecting On Consumer Retail Stocks' Q3 Earnings: Walgreens (NASDAQ:WBA)
This week's market focus: the USA's December non-farm payroll report is about to be released, and the Federal Reserve's meeting minutes are attracting attention.
Investors will pay attention to the important economic data to be announced soon and the signals that may be released in the Federal Reserve's meeting minutes.
The "January effect" in the U.S. stock market: Truth or myth?
The data supports this strategy, but also indicates that its effectiveness has weakened in recent years. As for 2025, the driving factors behind last year's high returns in the U.S. stock market still exist, but there are also some concerns.
Tech Stocks Top the Indexes Again, With One Mag 7 Caveat
Heard on the Street: 'The Broadening' in Stocks Might See Highfliers Retreat -- WSJ
Best and Worst Performing S&P 500 Stocks in a Rosy Year for Index